ARTICLE | Company News
Cord Blood Registry, AMAG Pharmaceuticals deal
September 21, 2015 7:00 AM UTC
AMAG completed its acquisition of stem cell company Cord Blood Registry for $700 million in cash from private equity firm GTCR (see BioCentury, July 13). ...